Australian shares are poised to rise on Monday after oil prices climbed as attacks claimed by Yemen's Iran-backed Houthis on Saudi Aramco sites raised concerns about potential disruptions to crude production.

Oil prices were also supported after the Organization of the Petroleum Exporting Countries decided to keep its November output targets unchanged, limiting expectations for additional supply and helping keep Brent crude above $100 a barrel amid the Iran war.

On Oct. 2, the S&P 500, the Nasdaq Composite, and the Dow Jones Industrial Average rose 0.7%, 1.2%, and 0.5%, respectively.

In the macroeconomy, Australia's private-sector growth slowed in September as weaker new business weighed on services activity, prompting a resumption of job cuts while inflationary pressures intensified, according to a monthly survey by S&P Global released Monday.

In corporate news, CSL (ASX:CSL) entered a partnership with Alentis Therapeutics to co-develop and co-promote lixudebart, a potential first-in-class therapy targeting rare kidney and liver diseases.

Capricorn Metals (ASX:CMM) produced 31,218 ounces of gold at its Karlawinda gold project in Western Australia during the September quarter, up from 30,437 ounces in the June quarter.

Australia's benchmark index rose 0.8%, or 67.7 points, to close at 8,682.10 on Oct. 2.